{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T04:07:45Z","timestamp":1788840465716,"version":"build-2803163510"},"reference-count":12,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","euoncology.europeanurology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Urology Oncology"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.euo.2026.08.011","type":"journal-article","created":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T03:31:38Z","timestamp":1788838298000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Transdermal Estradiol for Treating Prostate Cancer: Revisiting Huggins and Hodges\u2019 Revolutionary Breakthrough"],"prefix":"10.1016","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2392-886X","authenticated-orcid":false,"given":"David J.","family":"Benjamin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arash","family":"Rezazadeh Kalebasty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.euo.2026.08.011_b0005","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1056\/NEJMoa2511781","article-title":"Transdermal estradiol patches in locally advanced prostate cancer","volume":"394","author":"Langley","year":"2026","journal-title":"N Engl J Med"},{"key":"10.1016\/j.euo.2026.08.011_b0010","first-page":"293","article-title":"Studies on prostatic cancer. I. The effect of castration, of estrogen and of androgen injection on serum phosphatases in metastatic carcinoma of the prostate","volume":"1","author":"Huggins","year":"1941","journal-title":"Cancer Res"},{"key":"10.1016\/j.euo.2026.08.011_b0015","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1016\/S0022-5347(01)66670-9","article-title":"Estrogens in the treatment of prostate cancer","volume":"154","author":"Cox","year":"1995","journal-title":"J Urol"},{"key":"10.1016\/j.euo.2026.08.011_b0020","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1002\/1097-0142(197008)26:2<249::AID-CNCR2820260202>3.0.CO;2-7","article-title":"Incidence of cardiovascular disease and death in patients receiving diethylstilbestrol for carcinoma of the prostate","volume":"26","author":"Blackard","year":"1970","journal-title":"Cancer"},{"key":"10.1016\/j.euo.2026.08.011_b0025","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1056\/NEJM198411153112004","article-title":"Leuprolide versus diethylstilbestrol for metastatic prostate cancer","volume":"311","author":"Leuprolide Study Group","year":"1984","journal-title":"N Engl J Med"},{"key":"10.1016\/j.euo.2026.08.011_b0030","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1097\/01.ju.0000165567.99142.1f","article-title":"Transdermal estradiol therapy for prostate cancer reduces thrombophilic activation and protects against thromboembolism","volume":"174","author":"Ockrim","year":"2005","journal-title":"J Urol"},{"key":"10.1016\/j.euo.2026.08.011_b0035","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/S0140-6736(21)00100-8","article-title":"Transdermal oestradiol for androgen suppression in prostate cancer: long-term cardiovascular outcomes from the randomised Prostate Adenocarcinoma Transcutaneous Hormone (PATCH) trial programme","volume":"397","author":"Langley","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.euo.2026.08.011_b0040","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1002\/cncr.22991","article-title":"Pathologic fractures correlate with reduced survival in patients with malignant bone disease","volume":"110","author":"Saad","year":"2007","journal-title":"Cancer"},{"key":"10.1016\/j.euo.2026.08.011_b0045","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/S0022-5347(05)64561-2","article-title":"Skeletal fractures negatively correlate with overall survival in men with prostate cancer","volume":"168","author":"Oefelein","year":"2002","journal-title":"J Urol"},{"key":"10.1016\/j.euo.2026.08.011_b0050","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1200\/JCO.2026.44.7_suppl.338","article-title":"Patient (Pt) preferences for treatment (tx) of non-metastatic hormone-sensitive prostate cancer (nmHSPC): a discrete choice experiment (DCE)","volume":"44","author":"Shore","year":"2026","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.euo.2026.08.011_b0055","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1111\/j.1442-2042.2004.00896.x","article-title":"Influence of hot flashes on quality of life in patients with prostate cancer treated with androgen deprivation therapy","volume":"11","author":"Nishiyama","year":"2004","journal-title":"Int J Urol"},{"key":"10.1016\/j.euo.2026.08.011_b0060","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1016\/j.urology.2010.03.033","article-title":"Acupuncture for hot flashes in patients with prostate cancer","volume":"76","author":"Beer","year":"2010","journal-title":"Urology"}],"container-title":["European Urology Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2588931126002427?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2588931126002427?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T03:31:41Z","timestamp":1788838301000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2588931126002427"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":12,"alternative-id":["S2588931126002427"],"URL":"https:\/\/doi.org\/10.1016\/j.euo.2026.08.011","relation":{},"ISSN":["2588-9311"],"issn-type":[{"value":"2588-9311","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Transdermal Estradiol for Treating Prostate Cancer: Revisiting Huggins and Hodges\u2019 Revolutionary Breakthrough","name":"articletitle","label":"Article Title"},{"value":"European Urology Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.euo.2026.08.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 European Association of Urology. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}